<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02457494</url>
  </required_header>
  <id_info>
    <org_study_id>Al424-986</org_study_id>
    <nct_id>NCT02457494</nct_id>
  </id_info>
  <brief_title>Kidney Stone Risk Factors in Patients Infected With HIV</brief_title>
  <acronym>CALVIH</acronym>
  <official_title>CALVIH: Determination of Kidney Stone Risk Factors in Patients Infected With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corinne Isnard Bagnis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association pour le Developpement d'Investigations et de Thérapeutiques en Néphrologie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to define the cause of renal stones and the risk pattern for
      recurrence of renal stones episodes (any kind of stones) in HIV1 patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims at defining the cause of renal stones and the risk pattern for recurrence of
      renal stones episodes (any kind of stones) in HIV1 patients.

      Primary Objective :

        -  Finding the cause of renal stone in HIV patients defined as stone composition if stone
           is available or more probable pathophysiological mechanism

        -  Risk profile for stone recurrences estimated on risk indices in HIV1 patients

      Secondary Objective(s)

        -  Identify prevalence of recurrences and describe co-morbidities associated with stone
           disease

        -  Describe urological management for renal stones in HIV patients

        -  Describe the causes of drug induced renal stones
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative assessment of the cause of the renal stone</measure>
    <time_frame>at 6 months</time_frame>
    <description>Qualitative assessment of the cause of the renal stone based on different biological and clinical parameters (biochemical analysis of urines, cristalluria, low dose renal CT, patient history, family history…)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk profile for recurrence of renal stone</measure>
    <time_frame>at 12 months</time_frame>
    <description>Risk profile for recurrence of renal stone estimated based on plasma and urinary parameters, nutritional profile and drug exposure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Follow up outcome of HIV patients over one year to identify prevalence of recurrences and describe co-morbidities associated with stone disease</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urological management for renal stones in HIV patients</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Causes of drug induced renal stones</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of stone recurrences</measure>
    <time_frame>at 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of stone recurrences</measure>
    <time_frame>at 12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Nephrolithiasis</condition>
  <condition>HIV</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult male or female HIV1 infected patients having experienced a renal stone episode within
        the past six months or living with a renal stone
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male or female HIV1 infected patients willing to participate in the study

          -  Having experienced a renal stone episode within the past six months or living with a
             renal stone

          -  Able to understand the protocol

          -  Giving oral consent

        Exclusion Criteria:

          -  CT scan impossible

          -  Follow up impossible over 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>corinne i bagnis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Pitie Salpetriere et Chaire de Recherche en Education Therapeutique</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corinne i Bagnis, Professor</last_name>
    <phone>0033142177227</phone>
    <email>corinne.bagnis@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mansour Nassima, Master</last_name>
    <phone>0033142176060</phone>
    <email>nassima.mansour@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Corinne Isnard Bagnis</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>corinne bagnis, professor</last_name>
      <phone>00331 42 17 72 27</phone>
      <email>corinne.bagnis@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>nassima mansour, CRA</last_name>
      <phone>00331 42 17 60 60</phone>
      <email>nassima.mansour@aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P; French Hospital Database on HIV. A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial. Clin Infect Dis. 2015 Aug 1;61(3):375-84. doi: 10.1093/cid/civ310. Epub 2015 Apr 22.</citation>
    <PMID>25904366</PMID>
  </results_reference>
  <results_reference>
    <citation>Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013 Oct;24(10):1519-27. doi: 10.1681/ASN.2012080857. Epub 2013 Sep 19. Review.</citation>
    <PMID>24052632</PMID>
  </results_reference>
  <results_reference>
    <citation>Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C, Jidar K, Walker-Combrouze F, Peraldi MN, Isnard-Bagnis C, Servais A, Lortholary O, Noël LH, Bollée G. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant. 2012 Mar;27(3):1114-21. doi: 10.1093/ndt/gfr376. Epub 2011 Jul 10.</citation>
    <PMID>21745806</PMID>
  </results_reference>
  <results_reference>
    <citation>Tourret J, Tostivint I, Deray G, Isnard-Bagnis C. [Kidney diseases in HIV-infected patients]. Nephrol Ther. 2009 Nov;5(6):576-91. doi: 10.1016/j.nephro.2009.02.007. Epub 2009 Apr 16. French.</citation>
    <PMID>19375399</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2015</study_first_submitted>
  <study_first_submitted_qc>May 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2015</study_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Association pour le Developpement d'Investigations et de Thérapeutiques en Néphrologie</investigator_affiliation>
    <investigator_full_name>Corinne Isnard Bagnis</investigator_full_name>
    <investigator_title>University Professor and Hospital Practitioner</investigator_title>
  </responsible_party>
  <keyword>CALVIH</keyword>
  <keyword>Renal stone</keyword>
  <keyword>HIV1</keyword>
  <keyword>Renal colic</keyword>
  <keyword>Atazanavir</keyword>
  <keyword>Crystalluria</keyword>
  <keyword>Chronic Kidney Disease</keyword>
  <keyword>Calcium Oxalate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

